Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model
We assessed the torsadogenic effects of a novel remyelinating drug clemastine for multiple sclerosis using an in vivo proarrhythmia model of acute atrioventricular block rabbit, since the drug has been demonstrated to suppress the human ether-á-go-go related gene (hERG) K+ channels. Bradycardia was...
मुख्य लेखकों: | , , , , , |
---|---|
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
Elsevier
2020-11-01
|
श्रृंखला: | Journal of Pharmacological Sciences |
विषय: | |
ऑनलाइन पहुंच: | http://www.sciencedirect.com/science/article/pii/S1347861320300839 |